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Abstract
Background: Mastitis is an acute, debilitating condition that occurs in approximately 20 % of breastfeeding women
who experience a red, painful breast with fever. This paper describes the factors correlated with mastitis and investigates
the presence of Staphylococcus aureus in women who participated in the CASTLE (Candida and Staphylococcus
Transmission: Longitudinal Evaluation) study. The CASTLE study was a prospective cohort study which recruited
nulliparous women in late pregnancy in two maternity hospitals in Melbourne, Australia in 2009–2011.
Methods: Women completed questionnaires at recruitment and six time-points in the first eight weeks postpartum.
Postpartum questionnaires asked about incidences of mastitis, nipple damage, milk supply, expressing practices and
breastfeeding problems. Nasal and nipple swabs were collected from mothers and babies, as well as breast milk
samples. All samples were cultured for S. aureus. “Time at risk” of mastitis was defined as days between birth and
first occurrence of mastitis (for women who developed mastitis) and days between birth and the last study time-point
(for women who did not develop mastitis). Risk factors for incidence of mastitis occurring during the time at risk
(Incident Rate Ratios [IRR]) were investigated using a discrete version of the multivariable proportional hazards
regression model.
Results: Twenty percent (70/346) of participants developed mastitis. Women had an increased risk of developing
mastitis if they reported nipple damage (IRR 2.17, 95 % CI 1.21, 3.91), over-supply of breast milk (IRR 2.60, 95 % CI
1.58, 4.29), nipple shield use (IRR 2.93, 95 % CI 1.72, 5.01) or expressing several times a day (IRR 1.64, 95 % CI 1.01, 2.68).
The presence of S. aureus on the nipple (IRR 1.72, 95 % CI 1.04, 2.85) or in milk (IRR 1.78, 95 % CI 1.08, 2.92) also increased
the risk of developing mastitis.
Conclusions: Nipple damage, over-supply of breast milk, use of nipple shields and the presence of S. aureus on the
nipple or in breast milk increased the mastitis risk in our prospective cohort study sample. Reducing nipple damage
may help reduce maternal breast infections.
Keywords: Breastfeeding, Mastitis, Breast infection, Staphylococcus aureus
Background
Mastitis is an acute, debilitating condition that occurs in
approximately 20 % of breastfeeding women who ex-
perience a red, painful breast with fever [1–3]. It is a
distressing condition which negatively impacts the daily
activities of sufferers [4, 5]. Most episodes of mastitis
occur in the first two months postpartum [1–3] and re-
currence rates of up to about 10 % have been reported
[2, 3, 6]. Early management of mastitis involves general
measures to improve drainage of the breast and reduce
inflammation [7]. Medical management by general
practitioners in the community usually involves oral an-
tibiotics [8], with minimal interference to breastfeeding,
however some women require hospitalisation or develop a
breast abscess [9]. An earlier Melbourne-based study
found approximately 3 % of mastitis sufferers developed a
breast abscess subsequent to a mastitis episode [10].
Nipple pain and damage, maternal stress and fatigue,
attachment difficulties, milk stasis and restrictions from
a tight fitting bra have been implicated as contributing
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to mastitis [1, 3, 11–14]. Whereas some studies have
found that women with mastitis are not more or less
likely to continue breastfeeding than other women [1],
others have found that mastitis sufferers are more likely
to breastfeed for longer than women without mastitis
[15, 16]. There have been reports that women receiving
private or birth centre care are also more likely to de-
velop mastitis than other women [1, 17, 18]. Anecdotally
breast milk expression has been linked to mastitis, and
expressing breast milk has become more prevalent, even
for healthy term infants [19, 20], however this has not
been fully investigated. A recent study using a case-control
design found an association between using breast pumps
and mastitis, but questionnaire data were collected
retrospectively, not at the time of mastitis, so it is un-
clear if the expressing was a risk for or a consequence
of mastitis [21].
Traditionally, Staphylococcus aureus has been con-
sidered the most common aetiological agent of mastitis
and is frequently isolated in cases of infective mastitis
and breast abscesses [22, 23]. In a case-control study,
Amir et al. found that women with mastitis were more
likely to have S. aureus present in breast milk than
women in the control group [24]. At present, the role
of other organisms such as coagulase-negative S. aureus is
unclear [25, 26].
The aims of this prospective study are to describe the
incidence and correlates of mastitis in breastfeeding
women within the first two months after birth. We also
investigated the presence of S. aureus in milk during
mastitis episodes compared to milk samples collected
from healthy women during the study.
Methods
Sample
The CASTLE (Candida and Staphylococcus Transmission:
Longitudinal Evaluation) study investigated the microor-
ganisms involved in the development of mastitis and
“breast thrush” among breastfeeding women [27], and
confirmed the role of Candida species in the symptoms of
“breast thrush” [28]. Three hundred and sixty nulliparous
women were recruited from two hospitals in Melbourne,
Australia: the Royal Women’s Hospital, (RWH) a public
tertiary referral centre, and Frances Perry House (FPH), a
private co-located hospital. At recruitment participants
completed a questionnaire asking about maternal age,
gestational age, intended length of breastfeeding duration,
highest level of educational attainment, marital status and
previous staphylococcal infections. Following birth, par-
ticipants were followed-up six times: in hospital and
then at home weekly until four weeks postpartum and
at eight weeks by telephone.
Eligibility criteria for the study were: between 18–50 years
of age; nulliparity; ≥ 36 weeks pregnant at recruitment;
singleton pregnancy; breastfeeding intention for at least
eight weeks postpartum; sufficient proficiency in English to
complete written questionnaires and a telephone interview;
residing ≤ 16 km from Melbourne Central Business District
(CBD). Criteria for exclusion were: medical conditions
which do not allow breastfeeding; breast reduction surgery;
dermatitis on nipple during pregnancy; under care of the
Women’s Alcohol and Drug Service (WADS); under care
of Mental Health Service or social worker.
Data measures
Questionnaires
Self-administered questionnaires completed in hospital
after birth and at weeks 1, 2, 3, 4 and 8 postpartum
collected information about milk supply, nipple damage
and mastitis. At weeks 1, 2, 3, 4 and 8 postpartum
women were asked to rate their milk supply since their
last interview. They could state that they were “producing
enough milk for their baby”, “not producing enough milk”,
“over-producing breast milk” or that their “milk supply
varied”. They were also asked: “In the last week, have you
been expressing breast milk?” The women who had
expressed in the last week were asked “on average, how
often do you express?” and could select one of the fol-
lowing options: “once this week”, “several times this
week”, “once a day”; “several times a day” or “it varies” [29].
At all time-points postpartum, participants were asked
whether they had any nipple damage. If they had, they
could define this damage as a small graze/crack (<2 mm
in length), a moderate graze/crack (2 to 9 mm in length) or
a severe graze/crack (≥10 mm &/or yellow colour present).
Participants were given the opportunity to report any
problems they had with breastfeeding. At weeks 1, 2, 3,
4 and 8 postpartum women were asked whether they had
any problems with breastfeeding since their last interview.
They were supplied with a list of problems, including
attachment issues, over or under-supply of breast milk,
use of nipple shield to feed, having an unsettled infant, or
an infant not interested in feeding. Women were asked
about nipple pain and whether they had used any creams
or ointments on their nipples, including use of hydrated
polymer (hydrogel) dressings (results have been published
separately) [30, 31]. They could also state a breastfeeding
problem which was not listed.
There is no standard way of diagnosing mastitis. There-
fore, we asked about a range of breast symptoms and
associated fever or flu-like symptoms, as has been used
previously [1, 32]. For this analysis the definition of mas-
titis was the development of at least two breast symptoms
(pain, redness, lump) and at least one systemic symptom
(fever or flu-like symptoms) [1, 32] or treatment of
mastitis with antibiotics. Women were asked to rate
how mastitis had interfered with breastfeeding and with
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activities of daily living on a scale of 0 to 4 where 0 was
“no interference” and 4 was “quite a bit of interference” [5].
If a participant ceased breastfeeding during the first
four weeks postpartum, the subsequent home visits were
not conducted but the participant was contacted at eight
weeks to complete the final questionnaire by telephone.
Microbiology
Women provided nasal and nipple (both nipples) swabs
and breast milk samples (both breasts). Nasal and oral
swabs were obtained from infants. In addition, all women
were given a 70 ml sterile container (Sarstedt Australia
Pty. Ltd.) and asked to collect a sample of milk from the
affected breast should they develop mastitis during the
first eight weeks postpartum between their scheduled
weekly visits. Samples were collected and cultivated for
S. aureus as described in the study protocol [27].
Data analysis
Descriptive analysis included maternal demographic
characteristics and details about the birth, breastfeeding
duration, breastfeeding difficulties, and episodes of mas-
titis. Using information from the successive postpartum
time-points, we investigated possible predictors of (or
risk factors for) mastitis incidence. We defined “time at
risk” of mastitis as days between birth and first occurrence
of mastitis (for women who developed mastitis) and days
between birth and the last study time-point (for women
who did not develop mastitis). We used a discrete version
of the multivariate proportional hazards regression model
[33] to investigate whether mothers’ reported nipple
damage, “over-production of milk”, breastfeeding at-
tachment problems, use of nipple shield to feed, milk
expressing, use of hydrogel dressings, and presence of
S. aureus in samples collected from swabs and breast
milk samples were risk factors for mastitis incidence if
they occurred during the time at risk. For each of the
risk factors investigated (mothers’ reported nipple damage,
“over-production of milk”, etc), we estimated an incidence
rate ratio: the incidence rate of mastitis in those WITH
the risk factor during the “time at risk” divided by the inci-
dence rate of mastitis in those WITHOUT the risk factor
during the “time at risk”. We used the glm command in
Stata with link function = cloglog, family = binomial to
estimate the rate ratios. This method uses time at risk and
time-varying risk factors. Comparisons are presented
using incident rate ratios, 95 % confidence intervals (CIs),
and p-values. All analyses were carried out using Stata 13
software [34].
Ethics approval
The study received approval from La Trobe University
Human Ethics Committee (LTU UHEC No. 06-078), the
RWH Human Research Ethics Committee (RWH HREC
No. 06-41) and the Medical Advisory Committee at FPH.
All participants provided written informed consent.
Results
Sample
Three hundred and sixty women were recruited to the
CASTLE study between October 2009 and May 2011.
During the study, 14 women withdrew after giving birth,
leaving 346 women available for data collection (survey
results and microbiological data) at defined time-points
postpartum.
Information about the main socio-demographic charac-
teristics of the sample is shown in Table 1. Overall, the
women’s mean age was 32.7, with a range of between 19
and 44 years. Seventy seven percent of participants
(n = 267) held a University degree or higher, indicating
that this cohort represents a highly educated sample of
the general population. Breastfeeding intention ranged
from one month to 24 months, with a mean of ten
months. The method of birth was Caesarean section for
45 % of study participants. Ten percent of participants
(n = 36) reported suffering from previous staphylococ-
cal infections, such as boils, abscesses or sores inside
the nose.
Incidence of mastitis
Seventy women experienced mastitis, representing 20 %
of participants (70/346). There was no difference in the
prevalence of mastitis among public and private patients;
(40/192 private patients, 30/124 public patients expe-
rienced mastitis). There were 97 episodes of mastitis
in total. Figure 1 shows the proportion (%) of mastitis
Table 1 Characteristics of CASTLE study participants
Maternal characteristics (n = 346) n Percent
Hospital
Royal Women’s Hospital (public) 154 44.5
Frances Perry House (private) 192 55.5
Age (years - mean, SD, range) 32.7
(4.1, 19 - 44)
Education level
Tertiary degree or higher 267 77
Other 79 23
Breastfeeding intention
(months - mean, range)
9.7 (1 - 24)
Previous staphylococcal infections
(e.g. boils, abscesses, sores inside the nose)
Yes 284 82.1
No 36 10.4
Unsure 26 7.5
Caesarean birth 156 45
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episodes per week. Because women were contacted at
eight weeks postpartum and asked about mastitis epi-
sodes they experienced since their last home visit at
week 4, mastitis episodes experienced by women in
weeks 5 to 8 were averaged. Twenty four women expe-
rienced mastitis in this time period. The majority of
mastitis episodes (71 episodes, 73 % of the total) occurred
in the first four weeks postpartum. Forty eight women
experienced mastitis once, while 17 and 5 women expe-
rienced this condition two and three times respectively.
Mastitis sufferers were asked to rate how mastitis had
interfered with both breastfeeding and with activities of
daily living on a scale of 0 (no interference) to 4 (quite a
bit of interference). Fifty percent (35/70) of women with
mastitis reported that it interfered with breastfeeding
(scored 3 or 4 on a 4-point scale) and 60 % (42/70) of
women with mastitis reported that it interfered with
activities of daily living (scale as above).
Correlates of mastitis
The total “time at risk” (i.e. from birth to first mastitis or
last interview postpartum if no mastitis) was fifty person-
years. Potential correlates of mastitis incidence were inves-
tigated using information obtained from women at each
time-point on (i) their expressing habits, (ii) self-reported
breastfeeding problems and (iii) whether S. aureus was
isolated at each time-point in nipple and milk samples
from women or oral and nasal samples from infants
(Table 2). Specific potential determinants of mastitis in-
vestigated were: nipple damage; expressing several times
per day; attachment problems; over-supply of breast milk;
use of nipple shields; use of hydrogel dressings; S.aureus
cultured from nipple swabs collected from hospital
onwards; S. aureus cultured from milk samples from
hospital onwards and S. aureus cultured from the in-
fant (either from oral or nasal swabs) from hospital
onwards.
At each time-point in the first 4 weeks postpartum,
women who had already reported any nipple damage
had a more than two-fold increased risk of developing
mastitis compared to women without nipple damage
(Incident Rate Ratio (IRR) 2.17, 95 % CI 1.21, 3.91).
Similarly, women reporting an over-supply of breast
milk, attachment problems, nipple shield use or who
expressed several times a day had a significantly in-
creased risk of developing mastitis compared to
women who did not report these (Table 2). However,
women who reported any expressing in the week(s)
before questionnaire administration did not have an
increased risk of developing mastitis (IRR 1.35, 95 %
CI 0.70, 2.57). Mothers with S. aureus isolated from
their nipple and/or breast milk had an increased risk
of subsequently developing mastitis (nipple IRR 1.72,
95 % CI 1.04, 2.85, milk IRR 1.78, 95 % CI 1.08, 2.92).
The proportion of women who had S. aureus isolated
in their milk (Fig. 2) or nipple or milk (Fig. 3), are
shown at weeks 1, 2, 3 and 4. Women who developed
mastitis in the first 4 weeks were more likely to have
S. aureus isolated at each visit after week 1. There was
some evidence to suggest that use of hydrogel
dressings or S. aureus isolation from either infant nasal
or oral swabs led to an increased risk of developing
mastitis (hydrogel dressing use: IRR = 1.7; 95 % CI
0.96, 3.09; S. aureus isolation from either infant nasal
or oral swabs IRR 1.74, 95 % CI 0.97, 3.11). However,
maternal nasal carriage of S. aureus did not increase
the risk of risk of developing mastitis (IRR 1.11, 95 %
CI 0.68, 1.81).
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Fig. 1 Proportion (%) of mastitis episodes per week in women in the CASTLE study (n = 97 mastitis episodes in 70 women). Mastitis episodes in
weeks 5 to 8 were averaged; 24 women experienced mastitis in this time period
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S. aureus in breast milk samples
Breast milk samples were collected from 20 women
who reported mastitis at the time of collection or the
day before milk collection. Because mastitis could be
present in one breast or both breasts, in total 27 mas-
titis milk samples were collected from these 20 women
(Table 3). Fifty nine percent (16/27) of these milk
samples were culture-positive for S. aureus (95 % CI
39 %, 78 %).
Breast milk samples from women who did not report
mastitis at weeks 1, 2, 3 and 4 postpartum were also
cultivated for S. aureus (Table 3). Data are presented as
S. aureus positive milk samples collected per week.
Thirty two percent (207/657) of the milk samples col-
lected at week 1 were culture positive for S. aureus.
Culture positive milk samples at weeks 2, 3 and 4 were
26 % (172/660), 18 % (117/648) and 15 % (94/642)
respectively. S. aureus was isolated more frequently in
milk samples collected from women who reported
mastitis at the time, or the day before milk collection,
than from milk samples collected when women did
not report mastitis (Table 3).
Table 2 Correlates of mastitis incidence in women in the CASTLE study (n =346; 70 women with mastitis)
Correlate
(occurring from hospital onwards)
Number of women with at
least one mastitis event
Person-years at risk of
first mastitis event
Estimated Incidence
Rate Ratio (IRR)
95 % CI for IRR p value
Any nipple damage yes 55 31.8 2.17 1.21, 3.91 0.01
no 15 18.3
“Over-producing milk” yes 26 9.7 2.60 1.58, 4.29 <0.005
no 44 40.4
Attachment problem yes 45 24.3 1.96 1.18, 3.24 0.009
no 25 25.8
Use of nipple shield yes 23 7.4 2.93 1.72, 5.01 <0.005
no 47 42.7
Expressing several times a day yes 33 17.7 1.64 1.01, 2.68 0.047
no 37 32.4
Use of hydrogel dressings yes 15 7.0 1.72 0.96, 3.09 0.071
no 55 43.0
S. aureus isolated from nipple yes 46 26.5 1.72 1.04, 2.85 0.035
no 24 23.5
S. aureus isolated from milk yes 44 24.6 1.78 1.08, 2.92 0.023
no 26 25.4
S. aureus isolated from infants yes 55 34.1 1.74 0.97, 3.11 0.062
no 15 15.9
Fig. 2 Time to first isolation of Staphylococcus aureus in milk
(following hospital)
Fig. 3 Time to first isolation of Staphylococcus aureus on nipple or in
milk (following hospital)
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Discussion
Main findings
During the eight week study period, 20 % of participants
developed mastitis; the majority of episodes were re-
ported in the first four weeks postpartum. Women had
an increased risk of developing mastitis if they reported
nipple damage, problems with attachment, an over-
supply of breast milk, nipple shield use or if they re-
ported expressing breast milk several times a day. The
presence of S. aureus on the nipple or in breast milk
samples also increased the risk of developing mastitis
using a prospective study design.
Strengths and limitations
A strength of this study is that participants had not
previously breastfed or experienced mastitis; they were
recruited prior to starting breastfeeding. Some studies
have suggested that women who have previously expe-
rienced mastitis are more likely to experience this con-
dition again with subsequent infants [13, 14, 35]. Our
cohort was followed until eight weeks postpartum with
milk samples, breast and nipple analysis and detailed
questionnaires collected concurrently at defined time-
points, facilitating a comprehensive investigation of
the development of mastitis in the early weeks postpar-
tum. We also collected oral and nasal samples from in-
fants to investigate whether infant colonisation with S.
aureus could represent a potential route of transmis-
sion contributing to the development of mastitis. The
prospective data collection enabled us to conduct a
novel time-to-event analysis, whereas most studies of
mastitis have used retrospective data collection [21, 24].
A limitation of this study is that we relied on maternal
self-report for mastitis. We tried to overcome this by
using a strict definition of mastitis; two breast symptoms
and one systemic symptom, or treatment of mastitis
with antibiotics. We also relied on self-report for prob-
lems with breastfeeding such as an over-supply of breast
milk, problems with attachment and nipple shield use.
Further, although we followed the cohort until eight
weeks postpartum, we have microbiological data only to
four weeks postpartum and so we were unable to carry
out microbial assessments after this time.
Interpretation
We used a strict definition of mastitis in this study to
estimate the proportion of breastfeeding women who ex-
perienced a clinically significant illness. To reduce bias,
we did not ask participants about mastitis directly. Using
our definition, 20 % of the study population experienced
at least one episode of mastitis, which is in agreement
with several other Australian studies [1, 2, 36, 37]. How-
ever, in contrast to other studies [1, 17], mastitis was not
more prevalent among private patients than women
receiving public hospital care. This may be due to our
small sample size or the fact that women in our study
were followed only until eight weeks postpartum unlike
previous studies where participants were followed-up at
three months [17] and six months [1] after birth. It has
been shown that most episodes of mastitis occur in the
early weeks postpartum [1, 2]. In accordance with this,
approximately three-quarters of the mastitis episodes oc-
curred in the first four weeks postpartum in this study.
Episodes of mastitis peaked at two weeks postpartum
and decreased steadily after this point.
We investigated factors that could be correlated with
the development of mastitis. We confirmed the im-
portant role of nipple damage as well as problems with
attachment, over-supply of breast milk and use of a
nipple shield in the development of mastitis. Since over
90 % of participants used nipple creams we did not in-
clude this in our analysis [31]. It is clear that damage to
the nipple can contribute to mastitis [1–3, 12, 38]. Nipple
damage occurs most frequently in the early postpartum
period, suggesting that trauma to the nipple provides a
portal of entry for microorganisms from the damaged
skin into the nipple, leading to the development of
mastitis [1, 3, 38]. Preventing nipple trauma and im-
proving the management of damaged nipples could
reduce the risk of developing mastitis among breast-
feeding women. We confirmed previous reports that
attachment problems are also associated with the de-
velopment of mastitis [12]. It may be that incorrect
attachment leads to nipple trauma which then con-
tributes to the development of mastitis. Further, the
fact that nipple shield use was associated with mastitis in
our population suggests that some women who had nipple
trauma used nipple shields to feed.
Participants who indicated that they had an over-
supply of breast milk were also more likely to develop
mastitis. We postulate that mastitis is more likely to
occur in women with an over-supply of breast milk as
Table 3 Milk samples collected in women with and without
symptoms of mastitis in which S. aureus was isolated (total number
of women = 346)
S. aureus-positive milk samplesa n % (95 % CI)
Women with mastitis (n = 27)b 16 59.3 (39, 78)
Women without mastitis:
Week 1 (n = 657) 207 31.5 (28, 35)
Week 2 (n = 660) 172 26.1 (23, 29)
Week 3 (n = 648) 117 18.1 (15, 21)
Week 4 (n = 642) 94 14.6 (12, 17)
aSamples were collected separately for each breast
bMilk collected from women who reported mastitis at the time of collection or
the day before milk collection
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they may experience more engorgement and milk stasis,
which are known contributors to the development of
mastitis [12, 14]. This study adds to the evidence that
expressing several times each day is correlated with mas-
titis. Women who reported any expressing were not
more likely to experience mastitis, however women who
reported expressing several times a day had a higher risk
of developing mastitis. Women may be using regular
expressing to manage nipple trauma or an over-supply
of milk. Possibly, the increased practice of regular ex-
pressing [20, 39], may be exacerbating over-supply and
the risk of mastitis in some cases.
This study also investigated the role of S. aureus in
the development of mastitis. Although nasal carriage of
S. aureus plays a role in some infections [40], this
study, as well as the previous study by Amir et al.
found no association between maternal nasal carriage
of this bacteria and mastitis [24]. Women who were
culture-positive for S. aureus on their nipples or in
their expressed breast milk also had an increased risk
of developing mastitis. As S. aureus is the usual patho-
gen associated with mastitis in breastfeeding women
[22–24] we also investigated the presence of S. aureus
in breast milk from women with and without mastitis.
Milk samples collected from women who reported mas-
titis at the time of, or the day prior to milk collection
were more likely to grow S. aureus compared to sam-
ples from women without mastitis. This is in agreement
with previous reports [22–24], and highlights the role
of this species in the development of mastitis. Interest-
ingly, many milk samples from healthy women were
also positive for S. aureus, confirming the presence of
this organism as a commensal on the skin and in the
milk of healthy women who did not develop mastitis
[41]. As Ingman et al. explained: “the interactions
between inflammatory stimuli, including pathogenic
bacteria, and other components of the microbiome, as
well as the host immune response, are all likely to
contribute to shaping the severity of mastitis, duration
of symptoms and resolution of the disease” ([42] p. 1).
It is clear that mastitis impacts negatively on women’s
lives; participants reported that their mastitis symptoms
interfered with breastfeeding and with activities of daily
living. In accordance with a previous study [5], partici-
pants reported that their symptoms had a greater im-
pact on activities of daily living than on breastfeeding.
The fact that mastitis has such a negative influence on
women’s lives underlines the need to investigate factors
that could be varied to reduce or prevent mastitis. The
prevention or early treatment of damaged nipples,
active management of breast engorgement and early
intervention to help with positioning and attachment
may potentially reduce the risk of mastitis in breast-
feeding women.
Conclusion
Twenty percent of CASTLE study participants developed
mastitis in the first eight weeks postpartum and this had a
negative impact on their lives. Nipple damage, problems
with attachment, over-supply of breast milk, expressing
several times a day, use of a nipple shield and S. aureus
presence on the nipple or in expressed breast milk in-
creased the risk of developing mastitis in our study
sample. Education on optimal positioning and attachment
leading to a reduction in nipple damage may reduce the
incidence of mastitis among breastfeeding women [43].
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